Literature DB >> 32348232

A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.

Fereshteh Ghiasvand1, Sepideh Zahak Miandoab2, Hamid Harandi3, Fereshteh Shahmari Golestan4, Seyed Ahmad Seyed Alinaghi3.   

Abstract

After the initial outbreak of the new Coronavirus in Wuhan at the end of December 2019, many new cases were reported in other provinces of China and also many other countries over the world, including South Korea, Italy, Iran, Japan, and 68 other countries. We present a case report of a 61-year-old woman with a history of diabetes mellitus who was referred to the emergency department of a referral hospital in Tehran, Iran. The patient presented with fever, chills, and myalgia within three days. Laboratory analysis showed increased levels of erythrocyte sedimentation rate (ESR), and mild leukopenia. SARS-CoV-2 PCR test -under the Iran Ministry of Health and Medical Education (MoH&ME) guidelines- was conducted and the result was positive. The chest X-ray showed bilateral ground-glass opacity. O2 saturation was 87% (without O2 therapy). The patient was hospitalized and treated with Oseltamivir 75 mg every 12 hours, Lopinavir/Ritonavir (Kaletra) 400/100 mg every 12 hours and hydroxychloroquine 400 mg stat. The patient's last O2 saturation measured was 93% and she had no fever on the 10th day of hospitalization. Therefore, she was discharged from hospital and quarantined at home according to the Iran Ministry of Health protocol. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  COVID-19; Coronavirus; SARS-CoV-2 PCR test; diabetes mellitus; ground glass Opacity; severe acute respiratoryzzm321990syndrome coronavirus 2

Mesh:

Year:  2020        PMID: 32348232     DOI: 10.2174/1871526520666200429115535

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  4 in total

Review 1.  Genetic susceptibility of COVID-19: a systematic review of current evidence.

Authors:  SeyedAhmad SeyedAlinaghi; Mohammad Mehrtak; Mehrzad MohsseniPour; Pegah Mirzapour; Alireza Barzegary; Pedram Habibi; Banafsheh Moradmand-Badie; Amir Masoud Afsahi; Amirali Karimi; Mohammad Heydari; Esmaeil Mehraeen; Omid Dadras; Jean-Marc Sabatier; Fabricio Voltarelli
Journal:  Eur J Med Res       Date:  2021-05-20       Impact factor: 2.175

Review 2.  Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence.

Authors:  Esmaeil Mehraeen; Farzane Behnezhad; Mohammad Amin Salehi; Tayebeh Noori; Hamid Harandi; SeyedAhmad SeyedAlinaghi
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-17       Impact factor: 2.503

3.  Reinfection risk of novel coronavirus (COVID-19): A systematic ‎review of current evidence.

Authors:  SeyedAhmad SeyedAlinaghi; Shahram Oliaei; Shaghayegh Kianzad; Amir Masoud Afsahi; Mehrzad MohsseniPour; Alireza Barzegary; Pegah Mirzapour; Farzane Behnezhad; Tayebeh Noori; Esmaeil Mehraeen; Omid Dadras; Fabricio Voltarelli; Jean-Marc Sabatier
Journal:  World J Virol       Date:  2020-12-15

4.  Recent progress of antiviral therapy for coronavirus disease 2019.

Authors:  Mengmeng Zhao; Jishou Zhang; Hanli Li; Zhen Luo; Jing Ye; Yao Xu; Zhen Wang; Di Ye; Jianfang Liu; Dan Li; Menglong Wang; Jun Wan
Journal:  Eur J Pharmacol       Date:  2020-10-24       Impact factor: 4.432

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.